Adagene Inc. (ADR) share price logo

Adagene Inc. (ADR)

NASDAQ: ADAG

$3.61

+0.03

(+0.84%)

Live

as on

Adagene Inc. (ADR) Stock Performance

as on July 18, 2026 at 3:19 am IST

  • Day's Low

    Day's High

    $3.31
    $3.67
    downward going graph

    8.31%

    Downside

    1.66%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.30
    $4.85
    downward going graph

    63.99%

    Downside

    34.35%

    Upside

    downward going graph

Adagene Inc. (ADR) share price movements today

Previous Close
$3.58
Open
$3.40
Volume
351.4K
Day's Low - High
$3.31 - $3.67
52 Week Low - High
$1.30 - $4.85

Adagene Inc. (ADR) Historical Returns

1 Month Return
+ 1.42 %
3 Month Return
-9.82 %
1 Year Return
+ 111.83 %
3 Year Return
+ 146.9 %
5 Year Return
-80.77 %

Adagene Inc. (ADR) Stock Fundamentals & Key Indicators

Check Adagene Inc. (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$242.5M

EPS (TTM)

-0.51

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-21.0M

Revenue (TTM)

7.7M

Profit Margin

-229.56%

Return On Equity TTM

-34.39%

Adagene Inc. (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adagene Inc. (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Adagene Inc. (ADR) image
Adagene Inc. (ADR)
BUY$242.5M-80.77%NA-229.56%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.2B501.07%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$122.9B140.28%28.7635.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$71.2B16.41%16.5929.65%0.54%

Stock Returns calculator for Adagene Inc. (ADR) Stock including INR - Dollar returns

The Adagene Inc. (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Adagene Inc. (ADR) investment value today

Current value as on today

₹2,39,021

Returns

₹1,39,021

(+139.02%)

Returns from Adagene Inc. (ADR) Stock

₹1,13,609 (+113.61%)

Dollar Impact

₹25,412 (+25.41%)

Analyst Recommendation on Adagene Inc. (ADR) Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Adagene Inc. (ADR). Average target price of $9.4

Adagene Inc. (ADR) Share Price Target

Get share price movements and forecasts by analysts on Adagene Inc. (ADR).

What analysts predicted

61.6%UPSIDE

Target Price

$9.4

Current Price

$3.61

Analyzed by

8 Analysts

Target

$9.40

Adagene Inc. (ADR) target price $9.4, a slight upside of 61.6% compared to current price of $3.61. According to 8 analysts rating.

Indian Investors' Interest in Adagene Inc. (ADR) Stock

Search interest for Adagene Inc. (ADR) Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:33% versus previous 30 day period

Adagene Inc. (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Dec 2024
Mar 2026
Total Revenue
8
8
0
0
0
7
Gross Profit
8
17
0
0
0
7
Operating Income
-2
-2
-9
-9
-26
-5
EBITDA
-2
-2
-9
-9
-22
-5
Interest Expense
0
0
-
0
0
0
Depreciation
-
-
-
-
-
-
Income Before Tax
0
0
-7
-7
-24
-4
Income Tax Expense
1
1
0
0
0
0
Net Income
-2
-2
-7
-7
-24
-4
Net Profit Margin
-23.76%
-23.76%
-1818.90%
-1818.90%
-24144.66%
-53.87%

Adagene Inc. (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
0
10
9
18
0
7
Gross Profit
1
0
0
10
9
18
0
7
Operating Income
-17
-19
-19
-72
-83
-23
-35
-21
EBITDA
-14
-15
-41
-69
-77
-14
-31
-16
Interest Expense
0
0
0
0
0
1
0
0
Depreciation
0
0
0
1
1
1
0
0
Income Before Tax
-15
-16
-16
-71
-79
-17
-33
-17
Income Tax Expense
0
0
0
1
0
1
0
0
Net Income
-14
-17
-16
-73
-79
-18
-33
-17
Net Profit Margin
-974.03%
-3602.89%
-3424.06%
-719.18%
-860.59%
-104.61%
-32386.45%
-229.56%

Adagene Inc. (ADR) Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Mar 2026
Net Income
-2
-7
-7
-8
-8
-8
-24
-13
-4
Operating Cash Flow
-6
-
-15
-6
-6
-6
-23
-11
-4
Investing Cash Flow
0
-
-
0
-
0
0
0
0
Financing Cash Flow
0
-
-
0
0
-1
5
-11
16
Change in Cash
-14
-128
-18
-7
-7
-7
-10
-22
11

Adagene Inc. (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-42
-73
-79
-18
-33
-17
Operating Cash Flow
-18
-28
-43
-48
-28
-29
-15
Investing Cash Flow
24
7
-2
0
0
1
0
Financing Cash Flow
69
4
145
17
-5
3
4
Change in Cash
76
-17
99
-30
-33
-24
-10

Global Institutional Holdings in Adagene Inc. (ADR)

Funds
Holdings
Northwestern Mutual Wealth Management Co
0%
UBS Group AG
0.01%
Barclays PLC
0.39%
EverSource Wealth Advisors, LLC
0%
BlackRock Inc
0%
See all

Adagene Inc. (ADR) News & Key Events

    Insights on Adagene Inc. (ADR)

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 3 quarters, -24.91M → -4.14M (in $), with an average increase of 155.2% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 103.20K → 7.69M (in $), with an average increase of 98.7% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 6 months, ADAG stock has moved up by 82.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Revolution Medicines, Inc. Common Stock has given 358.8% return, outperforming this stock by 247.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.4% return, outperforming this stock by 426.5%

    About Adagene Inc. (ADR)

    Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. Adagene Inc. was incorporated in 2011 and is headquartered in Suzhou, China.
    OrganisationAdagene Inc. (ADR)
    HeadquartersBuilding C14, Suzhou, China, 215123
    IndustryBiotechnology
    CEODr. Peter P. Luo Ph.D.
    E-voting on sharesClick here to vote

    Key Management of Adagene Inc. (ADR)

    Name

    Title

    Mr. Mickael Chane-Du

    Chief Strategy Officer

    Ms. Xiaohong She

    Senior VP & Head of Clinical Operations

    Mr. Alexander Goergen

    VP & Head of Business Development

    Dr. Guizhong Liu Ph.D.

    Senior Vice President of Early Drug Discovery

    Dr. Peter P. Luo Ph.D.

    Co- Founder, Chairman, CEO and President of R&D

    Mr. Man Kin Tam M.B.A.

    CFO & Director

    Ms. Ling Zhou

    Executive Director & Head of Human Resources

    Dr. Qinghai Zhao Ph.D.

    Chief Manufacturing Officer

    Ms. Chunfang Gu

    Executive Director of Finance

    Ms. Yan Li M.B.A.

    Senior Vice President of Bioinformatics & Information Technology

    FAQs

    What is Adagene Inc. (ADR) share price today?

    Adagene Inc. (ADR) share price today is $3.61 as on . Adagene Inc. (ADR) share today touched a day high of $3.67 and a low of $3.31.

    What is the 52 week high and 52 week low for Adagene Inc. (ADR) share?

    Adagene Inc. (ADR) share touched a 52 week high of $4.85 on and a 52 week low of $1.30 on . Adagene Inc. (ADR) stock price today i.e. is trending at $3.61,which is 25.57% down from its 52 week high and 177.69% up from its 52 week low.

    What is Adagene Inc. (ADR)'s market capitalisation today?

    Adagene Inc. (ADR) market capitalisation is $0.00T as on .

    How to invest in Adagene Inc. (ADR) Stock (ADAG) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Adagene Inc. (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adagene Inc. (ADR) Shares that will get you 0.4155 shares as per Adagene Inc. (ADR) share price of $3.61 per share as on July 17, 2026 at 9:49 pm IST.

    What is the minimum amount required to buy Adagene Inc. (ADR) Stock (ADAG) from India?

    Indian investors can start investing in Adagene Inc. (ADR) (ADAG) shares with as little as ₹96.27 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹962.70 in Adagene Inc. (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Adagene Inc. (ADR) share’s latest price of $3.61 as on July 17, 2026 at 9:49 pm IST, you will get 2.7701 shares of Adagene Inc. (ADR). Learn more about fractional shares .

    What are the returns that Adagene Inc. (ADR) has given to Indian investors in the last 5 years?

    Adagene Inc. (ADR) stock has given -80.77% share price returns and 28.52% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?